Hugh John Willison
#163,177
Most Influential Person Now
Researcher
Hugh John Willison's AcademicInfluence.com Rankings
Hugh John Willisonengineering Degrees
Engineering
#7115
World Rank
#8477
Historical Rank
Electrical Engineering
#2192
World Rank
#2298
Historical Rank
Hugh John Willisoncomputer-science Degrees
Computer Science
#9557
World Rank
#10032
Historical Rank
Data Science
#234
World Rank
#239
Historical Rank
Computational Linguistics
#2328
World Rank
#2351
Historical Rank
Machine Learning
#4215
World Rank
#4264
Historical Rank
Download Badge
Engineering Computer Science
Hugh John Willison's Degrees
- PhD Computer Science Stanford University
- Masters Electrical Engineering University of California, Berkeley
Similar Degrees You Can Earn
Why Is Hugh John Willison Influential?
(Suggest an Edit or Addition)Hugh John Willison's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study (2016) (1876)
- Peripheral neuropathies and anti-glycolipid antibodies. (2002) (694)
- Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy (2001) (572)
- Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barre syndrome (1997) (542)
- Diagnosis and management of Guillain–Barré syndrome in ten steps (2019) (357)
- Guillain-Barré syndrome. (2016) (307)
- Anti‐GD1a antibody is associated with axonal but not demyelinating forms of Guillain‐Barré syndrome (1999) (305)
- The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies. (2001) (254)
- Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. (1993) (241)
- Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations. (1999) (222)
- Eculizumab prevents anti-ganglioside antibody-mediated neuropathy in a murine model. (2008) (220)
- Epidemiological and cohort study finds no association between COVID-19 and Guillain-Barré syndrome (2020) (207)
- Advances in understanding and treatment of immune‐mediated disorders of the peripheral nervous system (2004) (201)
- Motor nerve terminal degeneration provides a potential mechanism for rapid recovery in acute motor axonal neuropathy after campylobacter infection (1997) (194)
- Anti-GQ1b ganglioside antibodies mediate complement-dependent destruction of the motor nerve terminal. (2001) (194)
- The GD1a glycan is a cellular receptor for adenoviruses causing epidemic keratoconjunctivitis (2011) (188)
- The immunobiology of Guillain‐Barré syndromes (2005) (188)
- Serum factor in Miller-Fisher variant of Guillain-Barré syndrome and neurotransmitter release (1994) (162)
- Regional variation of Guillain-Barré syndrome (2018) (156)
- Regional variation of Guillain-Barré syndrome (2018) (156)
- Campylobacter jejuni lipopolysaccharides in Guillain-Barré syndrome (1998) (153)
- Anti-GD1a antibodies activate complement and calpain to injure distal motor nodes of Ranvier in mice. (2010) (151)
- The immunopathogenesis of Miller Fisher syndrome (1999) (144)
- Anti-disialoside antibodies kill perisynaptic Schwann cells and damage motor nerve terminals via membrane attack complex in a murine model of neuropathy. (2004) (142)
- A randomised controlled trial of intravenous immunoglobulin in IgM paraprotein associated demyelinating neuropathy (2002) (138)
- Structure of Campylobacter jejuni Lipopolysaccharides Determines Antiganglioside Specificity and Clinical Features of Guillain-Barré and Miller Fisher Patients (2002) (136)
- Immunolocalization of GQ1b and related gangliosides in human extraocular neuromuscular junctions and muscle spindles. (2009) (136)
- Miller Fisher anti‐GQ1b antibodies: α‐Latrotoxin–like effects on motor end plates (1999) (135)
- Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis (2012) (133)
- Guillain–Barré syndrome: a century of progress (2016) (133)
- Tetanus toxin is internalized by a sequential clathrin-dependent mechanism initiated within lipid microdomains and independent of epsin1 (2006) (131)
- Sialic Acid-Binding Immunoglobulin-Like Lectin 7 Mediates Selective Recognition of Sialylated Glycans Expressed on Campylobacter jejuni Lipooligosaccharides (2006) (128)
- Anti-ganglioside antibodies can bind peripheral nerve nodes of Ranvier and activate the complement cascade without inducing acute conduction block in vitro. (1999) (128)
- Demyelination induced by intraneural injection of human antimyelin‐associated glycoprotein antibodies (1988) (124)
- Infectious causes of acute flaccid paralysis (2003) (121)
- Inter‐laboratory validation of an ELISA for the determination of serum anti‐ganglioside antibodies (1999) (121)
- Acute oropharyngeal palsy is associated with antibodies to GQ1b and GT1a gangliosides. (1996) (118)
- Overexpression of GD1a Ganglioside Sensitizes Motor Nerve Terminals to Anti-GD1a Antibody-Mediated Injury in a Model of Acute Motor Axonal Neuropathy (2005) (118)
- Tolerance to Self Gangliosides Is the Major Factor Restricting the Antibody Response to Lipopolysaccharide Core Oligosaccharides in Campylobacter jejuni Strains Associated with Guillain-Barré Syndrome (2002) (117)
- Treatment for Fisher syndrome, Bickerstaff's brainstem encephalitis and related disorders. (2007) (116)
- The neuropathic potential of anti-GM1 autoantibodies is regulated by the local glycolipid environment in mice. (2009) (115)
- Immunoglobulin subclass distribution and binding characteristics of anti-GQ1b antibodies in Miller fisher syndrome (1994) (114)
- Complement inhibition abrogates nerve terminal injury in Miller Fisher syndrome (2005) (113)
- Multifocal motor neuropathy human sera block distal motor nerve conduction in mice (1995) (108)
- Complex Gangliosides at the Neuromuscular Junction Are Membrane Receptors for Autoantibodies and Botulinum Neurotoxin But Redundant for Normal Synaptic Function (2002) (107)
- A somatically mutated human antiganglioside IgM antibody that induces experimental neuropathy in mice is encoded by the variable region heavy chain gene, V1-18. (1996) (98)
- Immunoglobulins inhibit pathophysiological effects of anti-GQ1b-positive sera at motor nerve terminals through inhibition of antibody binding. (2003) (98)
- Calpain inhibitors protect against axonal degeneration in a model of anti-ganglioside antibody-mediated motor nerve terminal injury. (2003) (96)
- Antibodies to glycolipids in demyelinating diseases of the human peripheral nervous system. (1986) (90)
- Miller Fisher anti-GQ1b antibodies: alpha-latrotoxin-like effects on motor end plates. (1999) (88)
- Pathophysiological actions of neuropathy‐related anti‐ganglioside antibodies at the neuromuscular junction (2009) (88)
- An open label clinical trial of complement inhibition in multifocal motor neuropathy (2011) (86)
- Co-cultures with stem cell-derived human sensory neurons reveal regulators of peripheral myelination (2017) (81)
- Identification and Characterization of Gangliosides Reacting with IgM Paraproteins in Three Patients with Neuropathy Associated with Biclonal Gammopathy (1988) (81)
- Recent developments in Miller Fisher syndrome and related disorders (2005) (79)
- International Guillain‐Barré Syndrome Outcome Study: protocol of a prospective observational cohort study on clinical and biological predictors of disease course and outcome in Guillain‐Barré syndrome (2017) (79)
- The species distribution of nervous system antigens that react with anti-myelin-associated glycoprotein antibodies (1985) (78)
- Identity, developmental restriction and reactivity of extralaminar cells capping mammalian neuromuscular junctions (2008) (77)
- Peripheral neuropathy associated with monoclonal IgM anti-Pr2 cold agglutinins. (1993) (74)
- COVID-19 vaccine and Guillain-Barré syndrome: let’s not leap to associations (2020) (74)
- Acute immunoinflammatory neuropathy: update on Guillain-Barré syndrome. (2002) (73)
- Probing the cis interactions of the inhibitory receptor Siglec‐7 with α2,8‐disialylated ligands on natural killer cells and other leukocytes using glycan‐specific antibodies and by analysis of α2,8‐sialyltransferase gene expression (2006) (73)
- Variability in the binding of anti-MAG and anti-SGPG antibodies to target antigens in demyelinating neuropathy and IgM paraproteinemia (1999) (73)
- Patterns of Guillain-Barré syndrome in children (2007) (73)
- Lipid arrays identify myelin-derived lipids and lipid complexes as prominent targets for oligoclonal band antibodies in multiple sclerosis (2011) (73)
- Gangliosides and bacterial toxins in Guillain-Barré syndrome (1993) (72)
- Cost–utility analysis of intravenous immunoglobulin and prednisolone for chronic inflammatory demyelinating polyradiculoneuropathy (2003) (72)
- Neuroinflammation in the peripheral nerve: Cause, modulator, or bystander in peripheral neuropathies? (2015) (72)
- Sialoadhesin Promotes Rapid Proinflammatory and Type I IFN Responses to a Sialylated Pathogen, Campylobacter jejuni (2012) (71)
- Antibodies to gangliosides and myelin proteins in Guillain‐Barré syndrome (1990) (67)
- The role of complement and complement regulators in mediating motor nerve terminal injury in murine models of Guillain–Barré syndrome (2008) (67)
- Antibodies to Heteromeric Glycolipid Complexes in Guillain-Barré Syndrome (2013) (66)
- Acute ataxic neuropathy with cross‐reactive antibodies to GDlb and GD3 gangliosides (1994) (65)
- Synthetic disialylgalactose immunoadsorbents deplete anti-GQ1b antibodies from autoimmune neuropathy sera. (2003) (63)
- Inhibition of complement in Guillain‐Barré syndrome: the ICA‐GBS study (2017) (61)
- Analysis of lectin binding to glycolipid complexes using combinatorial glycoarrays. (2009) (61)
- Anti‐disialosyl antibodies mediate selective neuronal or Schwann cell injury at mouse neuromuscular junctions (2005) (61)
- Glycolipid antigens and autoantibodies in autoimmune neuropathies. (2013) (60)
- A randomized controlled trial of recombinant interferon-beta 1a in Guillain-Barré syndrome (2003) (59)
- Cloning of human anti‐GM1 antibodies from motor neuropathy patients (1994) (58)
- Mapping immunoreactive epitopes in the human peripheral nervous system using human monoclonal anti-GM1 ganglioside antibodies (1998) (58)
- Nerve root hypertrophy in chronic inflammatory demyelinating polyneuropathy (1994) (58)
- Anti-GM1 Ganglioside Antibodies Cloned from Autoimmune Neuropathy Patients Show Diverse Binding Patterns in the Rodent Nervous System (1996) (56)
- Subclass IgG to motor gangliosides related to infection and clinical course in Guillain–Barré syndrome (2008) (56)
- CLINICAL EVALUATION AND INVESTIGATION OF NEUROPATHY (2003) (55)
- Zika virus tropism and interactions in myelinating neural cell cultures: CNS cells and myelin are preferentially affected (2017) (55)
- Analysis of anti-GM1 ganglioside IgM antibodies cloned from motor neuropathy patients demonstrates diverse V region gene usage with extensive somatic mutation. (1995) (54)
- Neurological disease in adults with Zika and chikungunya virus infection in Northeast Brazil: a prospective observational study (2020) (54)
- Long‐term clinical and neurophysiological follow‐up of patients with peripheral, neuropathy associated with benign monoclonal gammopathy (2000) (53)
- A study of the relationship between neurological function and serum vitamin E concentrations in patients with cystic fibrosis. (1985) (53)
- Guillain-Barré Syndrome-Related Campylobacter jejuni in Bangladesh: Ganglioside Mimicry and Cross-Reactive Antibodies (2012) (52)
- Antiglycolipid antibodies in peripheral neuropathy: fact or fiction? (1994) (49)
- Peripheral Neuropathy Associated with Anti-GM2 Ganglioside Antibodies: Clinical and Immunopathological Studies (2000) (48)
- C5 inhibitor rEV576 protects against neural injury in an in vitro mouse model of Miller Fisher syndrome (2008) (47)
- Current treatment practice of Guillain-Barré syndrome (2019) (47)
- Solid phase immunoadsorption for therapeutic and analytical studies on neuropathy-associated anti-GM1 antibodies. (2007) (46)
- Adenovirus type 21-associated acute flaccid paralysis during an outbreak of hand-foot-and-mouth disease in Sarawak, Malaysia. (2003) (45)
- Anti-ganglioside antibody internalization attenuates motor nerve terminal injury in a mouse model of acute motor axonal neuropathy. (2012) (44)
- Nodes, paranodes and neuropathies (2017) (44)
- C1q-targeted inhibition of the classical complement pathway prevents injury in a novel mouse model of acute motor axonal neuropathy (2016) (44)
- Mechanisms of action of anti-GM1 and anti-GQ1b ganglioside antibodies in Guillain-Barré syndrome. (1997) (43)
- Neuronal Expression of GalNAc Transferase Is Sufficient to Prevent the Age-Related Neurodegenerative Phenotype of Complex Ganglioside-Deficient Mice (2014) (42)
- Randomized controlled trial of brain‐derived neurotrophic factor in Guillain–Barré syndrome: a pilot study (2000) (42)
- Detection and prevalence of α‐latrotoxin–like effects of serum from patients with Guillain–Barré syndrome (2002) (41)
- Diagnosis and treatment in inflammatory neuropathies (2009) (39)
- Autoimmune Neurological Conditions Associated With Zika Virus Infection (2018) (38)
- Characterisation of the immunoglobulin variable region gene usage encoding the murine anti-ganglioside antibody repertoire (2005) (38)
- Creutzfeldt-Jacob disease following cadaveric dura mater graft. (1991) (38)
- Complex Gangliosides as Autoantibody Targets at the Neuromuscular Junction in Miller Fisher Syndrome: A Current Perspective (2002) (37)
- Anti‐GQ1b antibodies and evoked acetylcholine release at mouse motor endplates (2000) (37)
- Sialylation of Campylobacter jejuni Lipo-Oligosaccharides: Impact on Phagocytosis and Cytokine Production in Mice (2012) (34)
- Anti-GD 1 a Antibody Is Associated with Axonal But Not Demyelinating Forms of Guillain-Barré Syndrome (1999) (34)
- Antiglycolipid antibodies, immunoglobulins and paraproteins in motor neuron disease: a population based case-control study (1993) (34)
- Ganglioside complexes: new autoantibody targets in Guillain–Barré syndromes (2005) (33)
- Muscle hypertrophy in multifocal motor neuropathy is associated with continuous motor unit activity (1997) (33)
- Synthesis of ganglioside epitopes for oligosaccharide specific immunoadsorption therapy of Guillian-Barré syndrome. (2004) (32)
- Innate murine B cells produce anti-disialosyl antibodies reactive with Campylobacter jejuni LPS and gangliosides that are polyreactive and encoded by a restricted set of unmutated V genes (2004) (31)
- Anti‐GM2 ganglioside antibodies are a biomarker for acute canine polyradiculoneuritis (2013) (31)
- Antiganglioside, antiganglioside-complex, and antiglycolipid-complex antibodies in immune-mediated neuropathies. (2016) (31)
- Motor nerve terminal destruction and regeneration following anti-ganglioside antibody and complement-mediated injury: An in and ex vivo imaging study in the mouse (2012) (30)
- Autoimmune ataxic neuropathies (sensory ganglionopathies). (1997) (30)
- Ganglioside antibodies and neuropathies (2008) (29)
- Monoclonal IgM Cold Agglutinins with Anti‐Pr1d Specificity in a Patient with Peripheral Neuropathy (1994) (28)
- Glial Sulfatides and Neuronal Complex Gangliosides Are Functionally Interdependent in Maintaining Myelinating Axon Integrity (2018) (28)
- Neuromuscular synaptic function in mice lacking major subsets of gangliosides (2008) (28)
- The role of antiglycolipid antibodies in peripheral neuropathies (2000) (27)
- Anti‐ganglioside Antibodies and the Presynaptic Motor Nerve Terminal (2008) (27)
- Autoantibodies in immune-mediated neuropathies. (2012) (27)
- Human Monoclonal Immunoglobulin M Antibodies to Ganglioside GM1 Show Diverse Cross-Reactivities with Lipopolysaccharides of Campylobacter jejuni Strains Associated with Guillain-Barré Syndrome (1999) (27)
- Anti-ganglioside antibodies are removed from circulation in mice by neuronal endocytosis (2016) (27)
- Peroxisomal dysfunctions cause lysosomal storage and axonal Kv1 channel redistribution in peripheral neuropathy (2017) (26)
- Glycoconjugates in nervous tissue and small cell lung cancer share immunologically cross-reactive carbohydrate determinants (1986) (26)
- Gangliosides as targets for autoimmune injury to the nervous system (2007) (26)
- The application of glycosphingolipid arrays to autoantibody detection in neuroimmunological disorders. (2014) (26)
- Human IgM paraproteins demonstrate shared reactivity between Campylobacter jejuni lipopolysaccharides and human peripheral nerve disialylated gangliosides (1997) (26)
- Guillain-Barré syndrome in the 100 years since its description by Guillain, Barré and Strohl. (2016) (26)
- ZikaPLAN: Zika Preparedness Latin American Network (2017) (25)
- MyelinJ: an ImageJ macro for high throughput analysis of myelinating cultures (2019) (25)
- Heteromeric glycolipid complexes as modulators of autoantibody and lectin binding. (2010) (24)
- Autoimmune responses in peripheral nerve (2004) (24)
- Immune‐mediated peripheral neuropathies and voltage‐gated sodiums channels (1999) (23)
- Acute motor neuropathy with antibodies to GM1 ganglioside (1991) (23)
- Improving the detection of IgM antibodies against glycolipids complexes of GM1 and Galactocerebroside in Multifocal Motor Neuropathy using glycoarray and ELISA assays (2015) (22)
- Microarray screening of Guillain-Barré syndrome sera for antibodies to glycolipid complexes (2016) (21)
- The expression of myelin-associated glycoprotein in regenerating cat sciatic nerve (1988) (21)
- Myelin‐Associated Glycoprotein and Related Glycoconjugates in Developing Cat Peripheral Nerve: A Correlative Biochemical and Morphometric Study (1987) (20)
- Roles of Complex Gangliosides at the Neuromuscular Junction (2003) (20)
- Guillain-Barré syndrome during the Zika virus outbreak in Northeast Brazil: An observational cohort study (2020) (20)
- Zika virus infection in the returning traveller: what every neurologist should know (2018) (20)
- Guillain–Barré syndrome serum and anti-Campylobacter antibody do not exacerbate experimental autoimmune neuritis (2001) (18)
- Fine specificity of anti-GQ1b antibodies and clinical features (2001) (18)
- Autoantibodies, neurotoxins and the nervous system (1995) (18)
- Gangliosides and Autoimmune Peripheral Nerve Diseases. (2018) (18)
- Neuromuscular synaptic transmission in aged ganglioside-deficient mice (2011) (18)
- Ganglioside GM1 binding toxins and human neuropathy-associated IgM antibodies differentially promote neuritogenesis in a PC12 assay (2003) (17)
- The translation of the pathological findings described in humans to experimental models of acute motor axonal neuropathy (2012) (17)
- The pre‐synaptic motor nerve terminal as a site for antibody‐mediated neurotoxicity in autoimmune neuropathies and synaptopathies (2014) (17)
- Mouse monoclonal and rabbit polyclonal antibodies prepared to human myelin-associated glycoprotein also react with glycosphingolipids of peripheral nerve (1986) (17)
- Autoimmunity and inflammation in the peripheral nervous system (2002) (16)
- Guillain-Barré Syndrome Outbreak in Peru 2019 Associated With Campylobacter jejuni Infection (2021) (16)
- Lesson of the Week: False localising signs in the spinal cord (1996) (16)
- Ganglioside complexes as targets for antibodies in Miller Fisher syndrome (2006) (16)
- EFNS Task Force Report: a questionnaire‐based survey on the service provision and quality assurance for determination of diagnostic autoantibody tests in European neuroimmunology centres (2000) (16)
- Induction of human IgM and IgG anti-GM1 antibodies in transgenic mice in response to lipopolysaccharides from Campylobacter jejuni (2004) (15)
- Biomarkers in experimental models of antibody‐mediated neuropathies (2011) (15)
- SHORT REPORT Miller Fisher syndrome is associated with serum antibodies to GQlb ganglioside (15)
- Perisynaptic Schwann cells phagocytose nerve terminal debris in a mouse model of Guillain‐Barré syndrome (2020) (14)
- Antiganglioside antibodies in acute self-limiting ataxic neuropathy: incidence and significance (2001) (14)
- Antiglycolipid antibodies in Guillain-Barré and Fisher syndromes: discovery, current status and future perspective (2020) (14)
- ZikaPLAN: addressing the knowledge gaps and working towards a research preparedness network in the Americas (2019) (14)
- Combinatorial glycoarray. (2012) (13)
- Zika Virus Infection Leads to Demyelination and Axonal Injury in Mature CNS Cultures (2020) (13)
- Low sulfated heparins target multiple proteins for central nervous system repair (2018) (13)
- Asymptomatic dengue infection may trigger Guillain‐Barré syndrome (2016) (12)
- Peripheral neuropathies: Establishing common clinical research standards for CIDP (2011) (12)
- Sulfatide binding properties of murine and human antiganglioside antibodies. (2007) (12)
- Guillain-Barré syndrome: surveillance and cost of treatment strategies – Authors' reply (2017) (11)
- Neuropathophysiological potential of Guillain–Barré syndrome anti‐ganglioside‐complex antibodies at mouse motor nerve terminals (2011) (11)
- Total ganglioside ablation at mouse motor nerve terminals alters neurotransmitter release level (2010) (11)
- Apolipoprotein E genotypes and clinical outcome in Guillain-Barré syndrome (2003) (11)
- Lack of effect of Miller Fisher sera/plasmas on transmitter release from PC12 cells (1997) (10)
- Progress in inflammatory neuropathy —the legacy of Dr Jack Griffin (2015) (10)
- Oligodendrocytes are susceptible to Zika virus infection in a mouse model of perinatal exposure: Implications for CNS complications (2021) (10)
- In vitro analysis of glial cell function in ganglioside‐deficient mice (2009) (10)
- Anti-glycolipid antibodies in the diagnosis of autoimmune neuropathies. (2002) (9)
- Anti-ganglioside Antibodies in Peripheral Nerve Pathology. (2018) (9)
- SIADH in a patient with sensory ataxic neuropathy with anti-disialosyl antibodies (CANOMAD) (2009) (9)
- Concanavalin a inhibits pathophysiological effects of anti‐ganglioside GQ1b antibodies at the mouse neuromuscular synapse (2005) (9)
- Schwann cell nodal membrane disruption triggers bystander axonal degeneration in a Guillain-Barré syndrome mouse model (2022) (9)
- Paraproteinaemic neuropathy. (1994) (8)
- Ranvier revisited (2014) (8)
- Anti-GQ1b ganglioside positive Miller Fisher syndrome - evidence of paranodal pathology on nerve biopsy. (2014) (8)
- Heparanase attenuates axon degeneration following sciatic nerve transection (2018) (8)
- Chapter 101 – Multifocal Motor Neuropathy and Conduction Block (2005) (8)
- Neurofascin antibodies in inflammatory neuropathy (2012) (8)
- The Diagnostic Utility of Determining Anti-GM1: GalC Complex Antibodies in Multifocal Motor Neuropathy: A Validation Study (2015) (8)
- Glycoconjugates and neuroimmunological diseases. (2014) (8)
- 230th ENMC International Workshop: Improving future assessment and research in IgM anti-MAG peripheral neuropathy: A consensus collaborative effort, Naarden, The Netherlands, 24–26 February 2017 (2017) (7)
- Prospective study comparing enzyme‐linked immunosorbent assay and glycoarray assay to detect antiglycolipid antibodies in a routine diagnostic neuroimmunology laboratory setting (2015) (6)
- Differential binding patterns of anti-sulfatide antibodies to glial membranes (2018) (6)
- Predicting Outcome in Guillain-Barré Syndrome (2021) (6)
- Visual improvement in established central retinal vein occlusion with long-standing macular edema following systemic eculizumab treatment. (2010) (6)
- Spinal nerve root hypertrophy in chronic ataxic neuropathy with antiglycolipid IgM antibodies (2010) (5)
- The Effects of Age and Ganglioside Composition on the Rate of Motor Nerve Terminal Regeneration Following Antibody-Mediated Injury in Mice (2013) (5)
- SARM1 Depletion Slows Axon Degeneration in a CNS Model of Neurotropic Viral Infection (2022) (5)
- GEMS–RCPSG: ‘Is Academic Medicine for Me?’ National Conference 2011, 19 November 2011 (2012) (5)
- The role of gangliosides in the organisation of the node of Ranvier examined in glycosyltransferase transgenic mice (2021) (4)
- Real time imaging of intra-axonal calcium flux in an explant mouse model of axonal Guillain-Barré syndrome (2022) (4)
- Glycosphingolipid depletion in PC12 cells using iminosugars protects neuronal membranes from anti-ganglioside antibody mediated injury (2008) (4)
- [Anti-glycolipid antibodies in the diagnosis of autoimmune neuropathies] (2002) (4)
- GBS100: Celebrating a Century of Progress in Guillain-Barré Syndrome (2016) (4)
- An International Perspective on Preceding Infections in Guillain-Barré Syndrome (2022) (3)
- Serum anti-GM2 and anti-GalNAc-GD1a IgG antibodies are biomarkers for acute canine polyradiculoneuritis. (2021) (3)
- Management of drug budgets (1999) (3)
- Antibodies to GM1: galactocerebroside complexes in multifocal motor neuropathy: it takes two to tango (2013) (3)
- Chapter 26 – Peripheral Nerve Antigens (2005) (3)
- The Use of Myelinating Cultures as a Screen of Glycomolecules for CNS Repair (2019) (3)
- The legacy of ZikaPLAN: a transnational research consortium addressing Zika (2021) (3)
- Use of Antibody Testing in Nervous System Disorders (2010) (3)
- Immunoglobulin G subclasses are normal in motor neuron disease (1994) (3)
- Antibodies to MOG in NMO (2012) (3)
- The fine specificity of anti-GM1 antibodies. (1993) (3)
- Peripheral neuropathies: Biomarkers for axonal damage in immune-mediated neuropathy (2009) (3)
- Electrodiagnosis of Guillain-Barre syndrome in the International GBS Outcome Study: Differences in methods and reference values (2022) (3)
- Diagnosis and treatment in inflammatory neuropathies. (2009) (2)
- A pilot randomised, double blind, placebo controlled exploratory safety study of the use of interferon-beta 1a in the treatment of Guillain-Barre syndrome (2004) (2)
- COMBINATORIAL GLYCOARRAY DETECTS DIVERSE NEW ANTIBODY SPECIFICITIES IN GUILLAIN-BARRE SYNDROME (2011) (2)
- Post-Infectious Autoimmunity in the Central (CNS) and Peripheral (PNS) Nervous Systems: An African Perspective (2022) (2)
- Reply: Guillain-Barré syndrome, SARS-CoV-2 and molecular mimicry and Ongoing challenges in unravelling the association between COVID-19 and Guillain-Barré syndrome and Unclear association between COVID-19 and Guillain-Barré syndrome and Currently available data regarding the potential association be (2021) (2)
- Neuronally expressed a‐series gangliosides are sufficient to prevent the lethal age‐dependent phenotype in GM3‐only expressing mice (2021) (2)
- Plasma from patients with raised anti-GM1 antibodies passively transfer conduction block (1994) (1)
- Involvement of cation channels in autoimmune disease. (1994) (1)
- Diagnosis and treatment in inflammatory neuropathies (Reprinted from Journal of Neurology, Neurosurgery, and Psychiatry, vol 80, pg 249-58, 2009) (2009) (1)
- A Tattoo Reveals Its Cold Secret (2003) (1)
- 1612 Combinatorial glycoarray detects diverse new antibody specificities in Guillain-BarrÉ syndrome (2012) (1)
- Randomized controlled trial of IVIg versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) (2001) (1)
- The endogenous calpain inhibitor calpastatin attenuates axon degeneration in murine Guillain‐Barré syndrome (2022) (1)
- [Evidence based guidelines. Diagnosis and management of Guillain-Barré syndrome in ten steps]. (2021) (1)
- 75 – GANGLIOSIDE AUTOANTIBODIES (2007) (1)
- Author response: Peroxisomal dysfunctions cause lysosomal storage and axonal Kv1 channel redistribution in peripheral neuropathy (2017) (1)
- Complement inhibition prevents glial nodal membrane injury in a GM1 antibody-mediated mouse model (2022) (1)
- BAF45b Is Required for Efficient Zika Virus Infection of HAP1 Cells (2021) (1)
- Campylobacter to a Sialylated Pathogen, Proinflammatory and Type I IFN Responses Sialoadhesin Promotes Rapid (2012) (0)
- Spinal arteriovenous malformation unmasked during intravenous urography. (1990) (0)
- Guillain-Barré Syndrome Following Zika Virus Infection Is Associated With a Diverse Spectrum of Peripheral Nerve Reactive Antibodies (2021) (0)
- Methods and compositions for the treatment of neuropathies mediated by antibodies (2007) (0)
- Use of Anti‐Nerve Antibodies (2008) (0)
- Reply: Neurofascin as target of autoantibodies in Guillain–Barré syndrome (2011) (0)
- A hazardous vapour trail from abattoir to neuropathy clinic (2010) (0)
- Heparanase attenuates axon degeneration following sciatic nerve transection (2018) (0)
- IN66-FR-03 Fisher syndrome (2009) (0)
- Zika virus infection of glia leads to secondary injury to axons and dendrites (2019) (0)
- Serum anti‐GM2 and anti‐GalNAc‐GD1a ganglioside IgG antibodies are biomarkers for immune‐mediated polyneuropathies in cats (2022) (0)
- RARITIES Multifocal motor neuropathy (2002) (0)
- ANALYSIS OF ANTI-GANGLIOSIDE COMPLEX ANTIBODIES IN HUMAN NEUROPATHY SERA USING COMBINATORIAL GLYCOARRAYS (2009) (0)
- Thanks to Editorial Board of Arquivos de Neuro-Psiquiatria (2021) (0)
- A COMBINATORIAL GLYCOLIPIDOMIC APPROACH TO THE IDENTIFICATION OF NEW MOLECULAR TARGETS IN GUILLAIN-BARRE SYNDROME (2009) (0)
- Thy-1 Mice Lend Themselves for the Modelling of Anti-ganglioside Antibody-mediated Disorders (2013) (0)
- -Depolarized Motor Neuron Terminals + -Induced Decline of Transmitter Release at K 2+ Role of Mitochondrial Dysfunction in the Ca (2015) (0)
- 06 - Is gangliosides array a good tool to diagnose inflammatory neuropathies in a routine diagnostic setting? A prospective comparison between ELISA and array assays to detect anti-gangliosides antibodies (2015) (0)
- Cerebrospinal Fluid Findings in Relation to Clinical Characteristics, Subtype, and Disease Course in Patients With Guillain-Barré Syndrome. (2023) (0)
- Commentary (1983) (0)
- Zika virus tropism and interactions in myelinating neural cell cultures: CNS cells and myelin are preferentially affected (2017) (0)
- DETECTION OF AUTOANTIBODY AND LECTIN BINDING TO GANGLIOSIDE COMPLEXES USING A NOVEL COMBINATORIAL GLYCOARRAY (2009) (0)
- C1q-targeted inhibition of the classical complement pathway prevents injury in a novel mouse model of acute motor axonal neuropathy (2016) (0)
- Rapid Injury and Steady Recovery of the Neuromuscular Nerve Terminal Integrity After Application of Anti-ganglioside Antibody in a Murine Model of Guillain-Barré Syndrome (2010) (0)
- Multifocal Motor Neuropathy (2002) (0)
- Author Response: An International Perspective on Preceding Infections in Guillain-Barré Syndrome: The IGOS-1000 Cohort (2023) (0)
- The Molecular Basis for Selective Involvement of the Extraocular Muscles in Miller Fisher Syndrome (2007) (0)
- Axolemmal nanoruptures arising from paranodal membrane injury induce secondary axon degeneration in murine Guillain‐Barré syndrome (2023) (0)
- Chronic inflammatory demyelinating polyradiculoneuropathy: classification and treatment options (2006) (0)
- The elusive diagnosis of sensory neuronopathy. (2019) (0)
- Treatment for Miller Fisher syndrome and related disorders (2004) (0)
- Autoantibodies to Glycolipids in Peripheral Neuropathy (2006) (0)
- Thanks to Editorial Board of Arquivos de Neuro-Psiquiatria (2022) (0)
- PRACTICES AND PREPARATIONS FOR THE TREATMENT OF antibody-mediated neuropathies (2007) (0)
- In memoriam: Remembering John W. 'Jack' Griffin M.D. (2011) (0)
- Complement-fixing Anti-ganglioside Antibodies in Acute Canine Polyradiculoneuritis (2016) (0)
- NEUROLOGICAL RARITIES Multifocal motor neuropathy (2002) (0)
- A glycolipidomic approach to the identification of new molecular targets in multiple sclerosis (2009) (0)
- King R. An Atlas of Peripheral Nerve Pathology Arnold, London, 1999. ISBN 0 340 586664. 217 pp h/b. Price £125.00 (2000) (0)
- Effects of Anti-ganglioside Antibodies at the Neuromuscular Junction (2012) (0)
- The spectrum of preceding infections in GBS - beyond Campylobacter (2016) (0)
- Antiganglioside antibodies in acute self‐limiting ataxic neuropathy: incidence and significance (2002) (0)
- Age-related Changes to the Distribution of Perisynaptic Schwann Cells at the Murine Neuromuscular Junction (2008) (0)
- A Combination of In Vivo and Ex Vivo Imaging to Monitor Degeneration and Regeneration of the Murine Neuromuscular Junction Following Immune-mediated Injury (2010) (0)
- Immunoglobulins inhibit pathophysiological effects of anti-GQ1b-positive sera at motor nerve terminals through inhibition of antibody binding☆ (2004) (0)
- The Sero-prevalence of Anti-glycolipid Antibodies in Acute Canine Polyradiculoneuritis and Other Peripheral and Cranial Neuropathies, Neuromuscular Disorders and Myopathies – Interim Report (2015) (0)
- Reply to correspondence from Dr Lo (2008) (0)
- for the Treatment of Mediterranean Visceral Leishmaniasis (2003) (0)
- Anti-ganglioside Antibodies As A Diagnostic Marker In Acute Canine Polyradiculoneuritis. (2012) (0)
- Detection of Autoantibodies Using Combinatorial Glycolipid Microarrays. (2022) (0)
- Crystal Structure of Ad37 fiber knob in complex with GD1a oligosaccharide (2010) (0)
- PS1-040. Targeting Sialoadhesin-positive macrophages in vivo by Campylobacter jejuni modulates TNF-alpha and IFN-beta production (2011) (0)
- Sugar refining reveals a further specificity for autoantibodies in multifocal motor neuropathy (2010) (0)
- 206. Ganglioside trafficking and antiganglioside antibodies (2015) (0)
- Researchers hone in on Zika’s neural target (2021) (0)
- C5 inhibition protect motor nerve terminals from membrane attack complex mediated injury in murine Miller Fisher syndrome (2007) (0)
- Pathogenic effects of antibodies from miller fisher syndrome in vitro (1994) (0)
- National scientific medical meeting 1997 abstracts (1998) (0)
- A novel MT-CO2 variant causing cerebellar ataxia and neuropathy: The role of muscle biopsy in diagnosis and defining pathogenicity (2021) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Hugh John Willison?
Hugh John Willison is affiliated with the following schools:
